These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2909522)

  • 41. Structural and functional properties of heparin analogues obtained by chemical sulphation of Escherichia coli K5 capsular polysaccharide.
    Razi N; Feyzi E; Björk I; Naggi A; Casu B; Lindahl U
    Biochem J; 1995 Jul; 309 ( Pt 2)(Pt 2):465-72. PubMed ID: 7626010
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Roles of N-terminal region residues Lys11, Arg13, and Arg24 of antithrombin in heparin recognition and in promotion and stabilization of the heparin-induced conformational change.
    Schedin-Weiss S; Desai UR; Bock SC; Olson ST; Björk I
    Biochemistry; 2004 Jan; 43(3):675-83. PubMed ID: 14730971
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The disaccharide composition of heparins and heparan sulfates.
    Guo YC; Conrad HE
    Anal Biochem; 1989 Jan; 176(1):96-104. PubMed ID: 2523675
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Biosynthesis of heparin. O-sulfation of D-glucuronic acid units.
    Kusche M; Lindahl U
    J Biol Chem; 1990 Sep; 265(26):15403-9. PubMed ID: 2118524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement.
    Olson ST; Björk I; Sheffer R; Craig PA; Shore JD; Choay J
    J Biol Chem; 1992 Jun; 267(18):12528-38. PubMed ID: 1618758
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Approaches to the synthesis of heparin.
    Lindahl U
    Haemostasis; 1990; 20 Suppl 1():146-53. PubMed ID: 2083867
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of a lysyl residue in antithrombin which is essential for heparin binding.
    Peterson CB; Noyes CM; Pecon JM; Church FC; Blackburn MN
    J Biol Chem; 1987 Jun; 262(17):8061-5. PubMed ID: 3110143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of critical molecular interactions mediating heparin activation of antithrombin: implications for the design of improved heparin anticoagulants.
    Olson ST; Björk I; Bock SC
    Trends Cardiovasc Med; 2002 Jul; 12(5):198-205. PubMed ID: 12161073
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis of heparin fragments. A chemical synthesis of the pentasaccharide O-(2-deoxy-2-sulfamido-6-O-sulfo-alpha-D-glucopyranosyl)-(1-4 )-O-(beta-D-glucopyranosyluronic acid)-(1-4)-O-(2-deoxy-2-sulfamido-3,6-di-O-sulfo-alpha-D-glu copyranosyl)-(1-4)-O-(2-O-sulfo-alpha-L-idopyranosyluronic acid)-(1-4)-2-deoxy-2-sulfamido-6-O-sulfo-D-glucopyranose decasodium salt, a heparin fragment having high affinity for antithrombin III.
    Petitou M; Duchaussoy P; Lederman I; Choay J; Sinaÿ P; Jacquinet JC; Torri G
    Carbohydr Res; 1986 Mar; 147(2):221-36. PubMed ID: 3708627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conformational transitions induced in heparin octasaccharides by binding with antithrombin III.
    Guerrini M; Guglieri S; Beccati D; Torri G; Viskov C; Mourier P
    Biochem J; 2006 Oct; 399(2):191-8. PubMed ID: 16796563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of arginine 129 in heparin binding and activation of antithrombin.
    Desai U; Swanson R; Bock SC; Bjork I; Olson ST
    J Biol Chem; 2000 Jun; 275(25):18976-84. PubMed ID: 10764763
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Location on heparin of the oligosaccharide section essential for anticoagulant activity.
    Radoff S; Danishefsky I
    J Biol Chem; 1984 Jan; 259(1):166-72. PubMed ID: 6706928
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Heterogeneous distribution of antithrombin-binding sites in rat brain heparan sulphate proteoglycans.
    Horner AA
    Biochem J; 1991 Dec; 280 ( Pt 2)(Pt 2):393-7. PubMed ID: 1747112
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Importance of lysine 125 for heparin binding and activation of antithrombin.
    Schedin-Weiss S; Desai UR; Bock SC; Gettins PG; Olson ST; Björk I
    Biochemistry; 2002 Apr; 41(15):4779-88. PubMed ID: 11939772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determination of the range in binding-site densities of rat skin heparin chains with high binding affinities for antithrombin.
    Horner AA; Kusche M; Lindahl U; Peterson CB
    Biochem J; 1988 Apr; 251(1):141-5. PubMed ID: 3390150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Probing the heparin-binding domain of human antithrombin III with V8 protease.
    Liu CS; Chang JY
    Eur J Biochem; 1987 Sep; 167(2):247-52. PubMed ID: 3305015
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular-size-dependent variations in the proportions of chains with high binding affinities for antithrombin in rat skin heparin proteoglycans.
    Horner AA
    Biochem J; 1989 Sep; 262(3):953-8. PubMed ID: 2590178
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The N-terminal segment of antithrombin acts as a steric gate for the binding of heparin.
    Fitton HL; Skinner R; Dafforn TR; Jin L; Pike RN
    Protein Sci; 1998 Mar; 7(3):782-8. PubMed ID: 9541411
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Heparin-like compounds prepared by chemical modification of capsular polysaccharide from E. coli K5.
    Casu B; Grazioli G; Razi N; Guerrini M; Naggi A; Torri G; Oreste P; Tursi F; Zoppetti G; Lindahl U
    Carbohydr Res; 1994 Oct; 263(2):271-84. PubMed ID: 7805054
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Conformational change in antithrombin induced by heparin probed with a monoclonal antibody against the 1C/4B region.
    Dawes J; James K; Lane DA
    Biochemistry; 1994 Apr; 33(14):4375-83. PubMed ID: 7512382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.